These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10454974)

  • 1. Grading, staging and scoring of left-ventricular hypertrophy, left-ventricular dilatation, asymptomatic left-ventricular dysfunction and chronic heart failure.
    Field ML; Coats AJ
    Eur Heart J; 1999 Sep; 20(17):1224-33. PubMed ID: 10454974
    [No Abstract]   [Full Text] [Related]  

  • 2. [From left hypertrophy to heart insufficiency: hemodynamic and clinical findings].
    Sütsch G; Boesiger P; Hess OM
    Praxis (Bern 1994); 1996 Feb; 85(8):218-26. PubMed ID: 8701188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular response to mitral regurgitation: implications for management.
    Gaasch WH; Meyer TE
    Circulation; 2008 Nov; 118(22):2298-303. PubMed ID: 19029478
    [No Abstract]   [Full Text] [Related]  

  • 6. A catheter based chronic porcine model of post-infarct dilated heart failure.
    Brødløs HK; Bramsen MB; Agger P; Jensen H; Bjerre M; Ringgaard S; Wierup P; Nielsen SL; Hasenkam JM; Smerup M
    Scand Cardiovasc J; 2009 Aug; 43(4):260-6. PubMed ID: 19065447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Left Ventricular Hypertrophy to Dysfunction and Failure.
    Lazzeroni D; Rimoldi O; Camici PG
    Circ J; 2016; 80(3):555-64. PubMed ID: 26853555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation.
    Kearney MT; Zaman A; Eckberg DL; Lee AJ; Fox KA; Shah AM; Prescott RJ; Shell WE; Charuvastra E; Callahan TS; Brooksby WP; Wright DJ; Gall NP; Nolan J
    J Card Fail; 2003 Apr; 9(2):93-9. PubMed ID: 12751129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.
    Perlini S
    J Hypertens; 2007 Jul; 25(7):1341-2. PubMed ID: 17563551
    [No Abstract]   [Full Text] [Related]  

  • 15. Transition from compensatory hypertrophy to dilated failing left ventricle in Dahl-Iwai salt-sensitive rats.
    Kihara Y; Sasayama S
    Am J Hypertens; 1997 May; 10(5 Pt 2):78S-82S. PubMed ID: 9160786
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.
    Cha YM; Redfield MM; Shen WK; Gersh BJ
    Circulation; 2004 Jun; 109(23):2839-43. PubMed ID: 15197156
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating diastolic heart failure: the role of ACE inhibitors.
    Bettencourt P
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V101-6. PubMed ID: 10582470
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure.
    Misra A; Diwan A; Mann DL; Deswal A
    Heart Fail Monit; 2002; 3(2):42-8. PubMed ID: 12634879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular reshaping with devices.
    Schenk S; Reichenspurner H
    Heart Surg Forum; 2003; 6(4):237-43. PubMed ID: 12928207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.